Home › Sickle Cell Disease › Mississippi › Jackson
Sickle Cell Disease clinical trials in Jackson, MS
5 studies for Sickle Cell Disease are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
RecruitingPhase 3
- Southern Specialty Clinic, Flowood · 3 mi away
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RecruitingPhase 3
- Southern Specialty Research, Flowood · 3 mi away
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
RecruitingPhase 2/3
- Southern Specialty Research, Flowood · 3 mi away
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
RecruitingPhase 2
- Southern Specialty Research, Flowood · 3 mi away
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
RecruitingPhase 3
- Southern Specialty Research- Site Number : 8400059, Flowood · 3 mi away
About Sickle Cell Disease
Sickle cell disease is a group of inherited disorders that affect your red blood cells. It can cause pain, anemia, and other problems. Learn about treatments.
More about Sickle Cell Disease on MedlinePlus
Sickle Cell Disease trials in other cities
- Atlanta, GA22 studies
- Washington, DC20 studies
- Chicago, IL18 studies
- Memphis, TN18 studies
- Philadelphia, PA15 studies
- Birmingham, AL14 studies
- New York City, NY13 studies
- St. Louis, MO12 studies
- Durham, NC10 studies
- Boston, MA10 studies
- Houston, TX10 studies
- Cincinnati, OH10 studies
Other studies in Jackson
- Obesity8 studies
- Overweight6 studies
- Steatotic Liver Disease5 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer5 studies
- Heart Failure5 studies
- Prostate Cancer5 studies
- Type 2 Diabetes5 studies
- Breast Cancer5 studies
- Attention Deficit Hyperactivity Disorder4 studies
- Burkitt Lymphoma4 studies
- Migraine4 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.